Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings crawled date : 2022 - 11 - 01 save search
Revance to Release Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
Published: 2022-11-01 (Crawled : 13:00) - biospace.com/
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.59%
H: 1.18%
C: 0.59%
RVNC | $3.77 -0.53% -0.53% 1.6M
|
Health Technology
|
| O: 0.85%
H: 1.73%
C: -0.18%
financial results
Intercept Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-01 (Crawled : 13:00) - biospace.com/
ICPT | $19.0 -0.05% 4M
|
Health Technology
|
| O: 7.35%
H: 9.34%
C: 5.64%
pharmaceuticals financial update results
Ecolab Third Quarter Reported Diluted EPS $1.21; Adjusted Diluted EPS $1.30 With Double-Digit Growth in Sales and Pricing; Expect Continued Improvement in Fourth Quarter 2022 Performance
Published: 2022-11-01 (Crawled : 13:00) - biospace.com/
ECL | News | $218.16 -0.48% 0.69% 2.6M
|
Process Industries
|
| O: -4.64%
H: 0.47%
C: -4.54%
sales growth
Chemomab Therapeutics to Report Third Quarter 2022 Financial Results and Provide a Business Update
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
CMMB | $0.691 -1.29% -1.3% 15K
|
Manufacturing
|
| O: -1.74%
H: 2.52%
C: 1.02%
report therapeutics financial update results
Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
HLN | $8.22 1.11% 0.0% 3.6M
|
n/a
|
| O: 0.16%
H: 1.79%
C: 0.16%
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.68%
H: 0.0%
C: -0.27%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 3.11%
H: 0.88%
C: 0.02%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.72%
H: 0.39%
C: -0.83%
BHVN 1 d | $38.99 -7.52% 0.0% 3.4M
|
Health Technology
|
| O: 1.81%
H: 3.08%
C: -0.65%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 4.54%
H: 4.25%
C: 0.13%
BEAM | $23.9 -1.69% -1.72% 4.5M
|
Health Technology
|
| O: 3.25%
H: 1.41%
C: -2.48%
ARVN | $34.78 1.43% 1.41% 940K
|
Health Technology
|
| O: 1.49%
H: 3.25%
C: 1.68%
results
Waters Corporation (NYSE: WAT) Reports Third Quarter 2022 Financial Results
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
WAT | $296.1 0.64% 0.0% 470K
|
Health Technology
|
| O: 1.57%
H: 2.26%
C: 1.18%
BRKR | $77.725 -1.06% -1.07% 1.3M
|
Health Technology
|
| O: 0.74%
H: 2.01%
C: 1.08%
corporation financial results
Pyxis Oncology Reports Financial Results for the Quarter Ended September 30, 2022 and Provides Corporate Update
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
PYXS | $4.155 -8.28% -9.03% 670K
|
Professional, Scientific, and T...
|
| O: 1.6%
H: 0.0%
C: -11.05%
financial update
IDEXX Laboratories Announces Third Quarter 2022 Results
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
IDXX | $476.29 -0.31% -0.31% 570K
|
Health Technology
|
| O: 4.28%
H: 6.82%
C: 5.3%
results
Axcella Reports Third Quarter Financial Results and Provides Business Update
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: -9.43%
financial update results
Catalent, Inc. Reports First Quarter Fiscal 2023 Results
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
CTLT | $55.48 -0.57% -0.4% 1.6M
|
Health Technology
|
| O: -25.04%
H: 9.17%
C: 0.53%
results
Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over Year
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
ABMD | $381.02 0.06% 0.07%
|
Health Technology
|
| O: 48.12%
H: 0.0%
C: 0.0%
year
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.47%
H: 0.09%
C: -0.55%
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.07%
H: 2.51%
C: -0.11%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: 3.1%
H: 1.8%
C: -0.6%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 1.59%
H: 7.26%
C: 1.89%
financial results
Neurocrine Biosciences Reports Third Quarter 2022 Financial Results and Raises 2022 INGREZZA Sales Guidance
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NBIX M | $132.03 -0.39% -0.39% 560K
|
Health Technology
|
| O: -0.1%
H: 7.37%
C: 3.79%
sales ingrezza financial results
Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
HRMY | $29.42 1.34% 1.33% 390K
|
Health Technology
|
| O: 5.1%
H: 8.45%
C: 8.44%
financial results
Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
RGEN | $157.12 0.04% 0.04% 380K
|
Health Technology
|
| O: -7.94%
H: 12.25%
C: 10.45%
year financial results
Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
XGN | $1.42 -0.62% -0.63% 6.6K
|
Health Services
|
| O: 0.78%
H: 9.3%
C: -5.04%
financial results
Apellis Pharmaceuticals to Host Conference Call on Nov 7, 2022 to Discuss Third Quarter 2022 Financial Results
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
APLS G | $47.53 0.04% 0.04% 1.2M
|
Health Technology
|
| O: -0.71%
H: 1.79%
C: 0.53%
pharmaceuticals conference financial results
Kiniksa Pharmaceuticals to Report Third Quarter 2022 Financial Results on November 1, 2022
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.74%
H: 2.09%
C: 0.48%
KNSA | $16.93 0.3% 0.3% 380K
|
Health Technology
|
| O: 0.26%
H: 1.53%
C: -2.81%
pharmaceuticals report financial results
Stryker reports third quarter 2022 operating results
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
SYK | $325.43 -0.62% 0.0% 1.8M
|
Health Technology
|
| O: -0.61%
H: 0.86%
C: 0.62%
results
Axonics® Reports Third Quarter 2022 Financial Results
Published: 2022-10-31 (Crawled : 00:00) - biospace.com/
AXNX | $66.96 -0.13% -0.13% 590K
|
Health Technology
|
| O: -1.04%
H: 5.61%
C: 2.8%
axonics financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.